, Portage Biotech Inc (NASDAQ:PRTG)’s traded shares were 3.52 million, with the beta value of the company hitting 99.74. , the stock’s price was $0.30, reflecting an intraday gain of 30.97% or $0.07. The 52-week high for the PRTG share is $3.95, that puts it down -1216.67 from that peak though still a striking 33.33% gain since the share price plummeted to a 52-week low of $0.20. The company’s market capitalization is $3.95M, and the average trade volume was 349.76K shares over the past three months.
Portage Biotech Inc (NASDAQ:PRTG) trade information
Portage Biotech Inc (PRTG) registered a 30.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 30.97% in intraday trading to $0.30, hitting a weekly high. The stock’s 5-day price performance is 21.81%, and it has moved by 15.62% in 30 days. Based on these gigs, the overall price performance for the year is -90.75%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Portage Biotech Inc (PRTG) estimates and forecasts
Statistics show that Portage Biotech Inc has outperformed its competitors in share price, compared to the industry in which it operates. Portage Biotech Inc (PRTG) shares have gone down -82.49% during the last six months, with a year-to-date growth rate more than the industry average at 84.13% against 15.50.
While earnings are projected to return 58.09% in 2024.
PRTG Dividends
Portage Biotech Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
